Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-19-012561
Filing Date
2019-05-07
Accepted
2019-05-07 19:01:05
Documents
2
Period of Report
2019-05-07

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3014
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4612
  Complete submission text file 0000899243-19-012561.txt   8994
Mailing Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510
Business Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510 203-304-2499
Trevi Therapeutics, Inc. (Issuer) CIK: 0001563880 (see all company filings)

EIN.: 450834299 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 301 COMMERCE STREET SUITE 3300 FORT WORTH TX 76102
Business Address
Nadav Eran (Reporting) CIK: 0001587852 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38886 | Film No.: 19804677